This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife's (MET) Arm MIM Closes $1.6B Private Equity Fund
by Zacks Equity Research
MetLife's (MET) business MIM used the secondaries market for third-party equity fund. The portfolio includes 80 fund positions across various sectors.
MetLife (MET) Arm Gets CBI License to Aid European Investors
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM receives a CBI authorization, which in turn, will help it deliver sound investment capabilities and benefit investors in the EEA.
RLI or KNSL: Which P&C Insurance Stock is Worth Investing?
by Zacks Equity Research
Let's see how RLI Corp. (RLI) and Kinsale Capital (KNSL) fare in terms of some of the key metrics.
Reasons Why Investing in RLI Stock is a Prudent Move Now
by Zacks Equity Research
RLI is well poised for growth on the back of its conservative investment strategy, sufficient liquidity and prudent capital deployment.
Is it the Right Time to Add Aflac (AFL) Stock to Your Kitty?
by Zacks Equity Research
Uptick in sales across Japan and U.S. segments, new business formation, investments for digital transformation and adequate cash generation abilities are likely to continue driving Aflac (AFL).
Why Should You Hold ProAssurance (PRA) in Your Portfolio?
by Zacks Equity Research
Banking on strategic growth initiatives and an improving top line, ProAssurance (PRA) holds the potential to reap benefits for investors.
RLI Continues to Gain From Solid Segmental Performance
by Zacks Equity Research
RLI is well-poised to gain from improved retention, rate increases, solid capital position and effective capital deployment.
Why Is RLI Corp. (RLI) Down 3.5% Since Last Earnings Report?
by Zacks Equity Research
RLI Corp. (RLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO Financial (CNO) Q4 Earnings Beat on Lower Benefits & Expenses
by Zacks Equity Research
CNO Financial's (CNO) fourth-quarter results gain from improved net investment income coupled with higher annuity collected premiums, partly offset by softer revenues.
Prudential Financial (PRU) Beats on Q4 Earnings, Hikes Dividend
by Zacks Equity Research
Prudential Financial's (PRU) fourth-quarter results benefit on the back of robust performances of U.S. Businesses and International Businesses, partly offset by a fall in overall revenues.
Aflac (AFL) Q4 Earnings Beat on Higher Variable Investment Income
by Zacks Equity Research
Aflac's (AFL) fourth-quarter results benefit from reduced operating costs, partly offset by a decline in revenues.
RLI Q4 Earnings Beat on Higher Underwriting, Revenues Miss
by Zacks Equity Research
RLI's Q4 results reflect a not-so-active catastrophe environment, favorable reserve development and solid investment returns.
P&C Insurance Stocks Q4 Earnings on Jan 26: PGR, RLI & AXS
by Tanuka De
Better pricing, exposure growth, solid retention, favorable renewals, reinsurance agreements, and accelerated digitalization are likely to favor fourth-quarter results of PGR, RLI and AXS.
Brown & Brown (BRO) Q4 Earnings & Revenues Top, Rise Y/Y
by Zacks Equity Research
Brown & Brown (BRO) Q4 earnings reflect improved organic growth and margin expansion.
Travelers (TRV) Q4 Earnings, Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Travelers (TRV) Q4 results reflect higher net investment income and a higher underlying underwriting gain, partially offset by lower net favorable prior year reserve development.
RLI Corp. (RLI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
RLI Corp. (RLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Lincoln National (LNC) Now
by Zacks Equity Research
Lincoln National (LNC) is well-poised for growth driven by improving revenues, diversified product suite and tactical capital deployment.
Here's Why Investors Should Consider Betting on RLI Stock
by Zacks Equity Research
RLI is poised for growth given its focus on specialty insurance lines, superior underwriting and sturdy financial position
Why Should You Add ProAssurance (PRA) to Your Portfolio?
by Zacks Equity Research
Riding on inorganic growth and cost-curbing measures, ProAssurance (PRA) holds the potential to reap benefits for investors.
Allstate (ALL) on Track to Sell Property to Reduce Expenses
by Zacks Equity Research
Allstate (ALL) to divest part of its Northbrook, IL property to warehouse builder Dermody Properties to cut down on expenses.
Why Should You Hold Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on inorganic growth measures and disciplined capital management, Marsh & McLennan (MMC) holds enough potential to reap benefits to investors.
Why Is RLI Corp. (RLI) Up 3.8% Since Last Earnings Report?
by Zacks Equity Research
RLI Corp. (RLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Primerica (PRI) Boosts Shareholder Value, Okays Share Buyback
by Zacks Equity Research
Primerica's (PRI) new $275 million buyback program reflects its commitment to enhance shareholders value.
Aflac (AFL) Okays 21.2% Dividend Hike, Boosts Shareholder Value
by Zacks Equity Research
Aflac's (AFL) latest dividend hike of 21.2% indicates a strong financial position and effective deployment of capital.
Here's Why You Should Consider Betting on RLI Stock Now
by Zacks Equity Research
RLI stands to benefit from a solid segmental performance and effective capital deployment.